ING Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.8M Sell
382,244
-29,553
-7% -$6.14M 0.44% 44
2026
Q1
$87M Sell
411,797
-18,409
-4% -$3.96M 0.53% 44
2025
Q4
$88.4M Sell
430,206
-87,864
-17% -$16.5M 0.53% 34
2025
Q3
$81.3M Sell
518,070
-77,635
-13% -$12M 0.44% 41
2025
Q2
$100M Buy
595,705
+369,759
+164% +$54.9M 0.61% 29
2025
Q1
$31.1M Buy
225,946
+163,636
+263% +$20.9M 0.22% 78
2024
Q4
$7.37M Sell
62,310
-21,502
-26% -$2.51M 0.05% 233
2024
Q3
$9.26M Buy
+83,812
New +$8.76M 0.05% 218
2024
Q2
Sell
-33,330
Closed -$3.73M 550
2024
Q1
$3.73M Sell
33,330
-152,412
-82% -$16.4M 0.03% 367
2023
Q4
$18.7M Buy
185,742
+185,197
+33,981% +$18.4M 0.15% 137
2023
Q3
$47.3K Sell
545
-45,506
-99% -$4.11M ﹤0.01% 547
2023
Q2
$4.36M Buy
46,051
+38,513
+511% +$3.25M 0.03% 272
2023
Q1
$569K Sell
7,538
-190,183
-96% -$14.3M 0.01% 464
2022
Q4
$15.2M Buy
197,721
+154,441
+357% +$11.7M 0.15% 120
2022
Q3
$2.89M Sell
43,280
-10,164
-19% -$644K 0.05% 232
2022
Q2
$2.79M Buy
53,444
+8,150
+18% +$463K 0.03% 340
2022
Q1
$2.57M Sell
45,294
-41,021
-48% -$2.2M 0.03% 358
2021
Q4
$4.44M Buy
86,315
+60,849
+239% +$2.98M 0.04% 298
2021
Q3
$1.26M Sell
25,466
-134
-0.5% -$7.27K 0.02% 468
2021
Q2
$1.46M Buy
25,600
+3,500
+16% +$205K 0.02% 375
2021
Q1
$1.34M Sell
22,100
-1,719
-7% -$94.9K 0.03% 322
2020
Q4
$1.28M Buy
23,819
+12,990
+120% +$674K 0.03% 330
2020
Q3
$508K Buy
10,829
+4,002
+59% +$205K 0.02% 299
2020
Q2
$356K Sell
6,827
-2,879
-30% -$148K 0.02% 210
2020
Q1
$465K Sell
9,706
-14,713
-60% -$764K 0.02% 260
2019
Q4
$1.24M Buy
24,419
+18,457
+310% +$953K 0.04% 272
2019
Q3
$281K Sell
5,962
-42,974
-88% -$1.96M 0.01% 445
2019
Q2
$2.31M Buy
48,936
+22,192
+83% +$1.02M 0.04% 249
2019
Q1
$1.29M Sell
26,744
-12,262
-31% -$614K 0.03% 276
2018
Q4
$1.74M Sell
39,006
-72
-0.2% -$3.75K 0.04% 245
2018
Q3
$2.11M Buy
39,078
+34,188
+699% +$1.75M 0.04% 247
2018
Q2
$239K Sell
4,890
-2,722
-36% -$154K ﹤0.01% 664
2018
Q1
$477K Buy
+7,612
New +$522K 0.01% 485
2017
Q4
Sell
-3,828
Closed -$256K 773
2017
Q3
$256K Sell
3,828
-4,598
-55% -$325K ﹤0.01% 745
2017
Q2
$657K Sell
8,426
-4,929
-37% -$372K 0.01% 404
2017
Q1
$1.09M Sell
13,355
-2,339
-15% -$184K 0.02% 328
2016
Q4
$1.14M Buy
15,694
+6,637
+73% +$480K 0.02% 296
2016
Q3
$696K Sell
9,057
-3,677
-29% -$297K 0.01% 341
2016
Q2
$993K Buy
12,734
+4,733
+59% +$377K 0.01% 258
2016
Q1
$656K Sell
8,001
-185,688
-96% -$15.1M 0.01% 334
2015
Q4
$17.3M Buy
193,689
+13,521
+8% +$1.15M 0.1% 174
2015
Q3
$13.8M Sell
180,168
-8,564
-5% -$716K 0.1% 169
2015
Q2
$15.8M Buy
188,732
+162,518
+620% +$14.3M 0.09% 203
2015
Q1
$2.37M Buy
26,214
+23,056
+730% +$1.98M 0.01% 487
2014
Q4
$255K Sell
3,158
-345
-10% -$27.2K ﹤0.01% 736
2014
Q3
$262K Sell
3,503
-136,713
-98% -$9.95M ﹤0.01% 618
2014
Q2
$9.61M Buy
140,216
+41,400
+42% +$2.82M 0.05% 278
2014
Q1
$6.92M Sell
98,816
-120,826
-55% -$8.4M 0.04% 327
2013
Q4
$14.7M Sell
219,642
-444,917
-67% -$27.2M 0.07% 243
2013
Q3
$34.7M Sell
664,559
-44,419
-6% -$2.26M 0.17% 135
2013
Q2
$33.5M Buy
+708,978
New +$32.4M 0.18% 138

Other funds holding CAH

ING Group's CAH Position: Q2 2026 in Review

ING Group reduced its Cardinal Health (CAH) stake by 7.2% in Q2 2026, selling an estimated $6.14M and leaving 382,244 shares worth $90.8M. The position accounts for 0.44% of the portfolio, ranked #44.

ING Group first reported a position in CAH in Q2 2013 and has held it in 51 quarters since. The position peaked at $100M in Q2 2025. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • ING Group held 382,244 shares of Cardinal Health worth $90.8M as of Q2 2026.
  • ING Group sold 29,553 Cardinal Health shares in Q2 2026, an estimated $6.14M.
  • Cardinal Health made up 0.44% of ING Group's portfolio in Q2 2026, its #44 holding.
  • ING Group first reported a position in Cardinal Health in Q2 2013 and has held it in 51 quarters since.
  • ING Group's Cardinal Health position peaked at $100M in Q2 2025.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.